Table 3. Threshold values of influential parameters on the model results of a cost-effective strategy.
| Variable | Base-case value | Threshold value | Change of preferred cost-effective strategy (WTP = 7,055 USD/DALY) |
|---|---|---|---|
| Sensitivity of AlereLAM | 34.90% | >65.12% | AlereLAM +Xpert Ultra |
| Sensitivity of FujiLAM | 70.70% | <40.48% | AlereLAM +Xpert Ultra |
| Sensitivity of Xpert for MTB detection | 74.90% | >98.05% | Xpert |
| 87.58%-98.05% | FujiLAM + Xpert | ||
| Sensitivity of Xpert Ultra for MTB detection | 87.60% | >98.05% | Xpert Ultra |
| <74.94% | FujiLAM + Xpert | ||
| Sensitivity of Xpert Ultra for rifampicin resistance | 94.90% | <71.10% | FujiLAM + Xpert |
| Specificity of Xpert Ultra for rifampicin resistance | 99.10% | <90.50% | FujiLAM + Xpert |
DALY: disability-adjusted life years; MTB: Mycobacterium tuberculosis; WTP: willingness-to-pay